Brookdale Senior Living sits at the center of a long-arc demographic thesis, with the United States population aged 80 and over on track to roughly double over the next two decades, and a senior housing industry that has spent the last three years working through the deepest occupancy reset in its history. The second-quarter 2026 print captures the company in the middle of that reset, with same-community occupancy moving higher sequentially, with operating leverage showing up in resident fee revenue and adjusted EBITDA, and with the deleveraging cadence that the company has been signaling since 2024 visibly intact. We see the second-quarter print as evidence that the recovery is real, that the operating model is bending back toward pre-pandemic margin structure, and that the equity story is no longer a binary bet on occupancy normalization but a slower-burn question of how much of the pandemic-era margin compression reverses.
The numbers that frame the print are: roughly 640 communities across 41 states at quarter end, weighted toward assisted living and memory care where the demographic exposure and the private-pay mix are strongest, and a same-community weighted average occupancy that has improved from the low-80s percent range a year ago into the mid- to high-80s range, with the second quarter typically the seasonally strongest quarter of the year. Resident fee revenue is concentrated in private pay, with a Medicare-certified skilled nursing footprint that is small in the consolidated revenue mix but meaningful in the higher-acuity care continuum. Net debt sits in the high-single-digit billion-dollar area after several quarters of meaningful reduction, and the leverage ratio of net debt to adjusted EBITDA has come down materially from the 2022-2023 peak.
The trade we see is the gap between a senior housing recovery story that the equity market is starting to price in and a longer-dated demographic tailwind that compounds regardless of the cycle. The market is focused on the next two to four quarters of occupancy and rate trajectory, while the structural case rests on a 20-year compounding of the 80-plus population that is largely independent of short-term cyclical factors. We read the current valuation as neither cheap nor expensive on a forward-EBITDA basis, with the multiple constrained by the lingering balance-sheet weight but supported by the operating recovery and the demographic overlay. The monitoring items that follow track the speed of the occupancy recovery, the cadence of margin expansion, the path of net debt reduction, and the optionality around portfolio rationalization.